Matches in SemOpenAlex for { <https://semopenalex.org/work/W2479430346> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2479430346 abstract "Purpose. To determine whether RNAi-based combination therapy targeting androgen receptor (AR) and XIAP signaling pathways using polymeric micelles can treat prostate cancer. Methods. Potency of siRNAs targeting AR and XIAP genes was assessed using real time RT-PCR, Western Blot and ELISA. Cell viability was determined by MTT assay. A library of polymers designed to degrade via hydrolysis and enhance siRNA delivery was synthesized by conjugating hexylamine, pentaethylenehexamine and 3-morpholinopropylamine to poly(ethylene glycol)-block-poly(5-methyl-5-carboxyl-propylene carbonate) backbone using EDC/HOBT coupling chemistry. Polymer structure and molecular weight were verified with proton NMR and Gel Permeation Chromatography, respectively. Results. Three siRNA sequences targeting different regions of the AR and XIAP genes were designed, blasted against the human genome database to eliminate cross-silencing of nontarget genes and their potency screened in LNCaP and C4-2 cells following transfection. All siRNAs targeting AR (start site: 1172, 1648 and 1768) used in this study silenced AR mRNA and protein expression in both cell lines. Furthermore, 1172 was identified as the most potent sequence resulting in approximately 75% knockdown regardless of cell type. Also, the three siRNAs targeting XIAP (start site: 264, 297 and 458) down-regulated XIAP mRNA and protein levels in both cells and were generally more potent in C4-2 cells compared to LNCaP cells. C4-2 cells transfected with siRNA targeting AR (start site: 1172) and XIAP (start site: 264) alone or in combination and assayed after 96 hours revealed XIAP and AR down-regulation resulted in approximately 20% and 50% growth inhibition in C4-2 cells, respectively, compared to control. However, combined silencing of XIAP and AR genes decreased cell growth by 62% and was more potent in inhibiting cell proliferation compared to monotherapy. Additionally, combination of siRNA targeting AR (start site: 1172) and XIAP (start site: 264) significantly increased percentage of cells undergoing apoptosis (85%) compared to control or monotherapy. Poly(ethylene glycol)-block-poly(5-methyl-5-carboxyl-propylene carbonate) copolymer was synthesized by ring opening polymerization and conjugated with various ratios of hexylamine, pentaethylenehexamine and 3-morpholinopropylamine moieties. The resulting copolymer (PEG-b-P(CC-g-PHEXYL-g-PMORPH-g-PPHEA) were non-toxic even at concentration of 1500 μg/mL and successfully condensed siRNA at N/P of 25 with average hydrodynamic diameter of approximately 175 nm. Conclusions. Combination based therapy using siRNA targeting AR and XIAP can potentially treat prostate cancer. Citation Format: Michael Danquah. Polymer mediated RNAi-based combination therapy for treating prostate cancer. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2060." @default.
- W2479430346 created "2016-08-23" @default.
- W2479430346 creator A5040370583 @default.
- W2479430346 date "2016-07-15" @default.
- W2479430346 modified "2023-09-26" @default.
- W2479430346 title "Abstract 2060: Polymer mediated RNAi-based combination therapy for treating prostate cancer" @default.
- W2479430346 doi "https://doi.org/10.1158/1538-7445.am2016-2060" @default.
- W2479430346 hasPublicationYear "2016" @default.
- W2479430346 type Work @default.
- W2479430346 sameAs 2479430346 @default.
- W2479430346 citedByCount "0" @default.
- W2479430346 crossrefType "proceedings-article" @default.
- W2479430346 hasAuthorship W2479430346A5040370583 @default.
- W2479430346 hasConcept C104317684 @default.
- W2479430346 hasConcept C119056186 @default.
- W2479430346 hasConcept C121608353 @default.
- W2479430346 hasConcept C1491633281 @default.
- W2479430346 hasConcept C153911025 @default.
- W2479430346 hasConcept C166703698 @default.
- W2479430346 hasConcept C173396325 @default.
- W2479430346 hasConcept C185592680 @default.
- W2479430346 hasConcept C190283241 @default.
- W2479430346 hasConcept C22615655 @default.
- W2479430346 hasConcept C2777366897 @default.
- W2479430346 hasConcept C2779723316 @default.
- W2479430346 hasConcept C2780192828 @default.
- W2479430346 hasConcept C2780783641 @default.
- W2479430346 hasConcept C31573885 @default.
- W2479430346 hasConcept C33195913 @default.
- W2479430346 hasConcept C502942594 @default.
- W2479430346 hasConcept C54009773 @default.
- W2479430346 hasConcept C54355233 @default.
- W2479430346 hasConcept C55493867 @default.
- W2479430346 hasConcept C67705224 @default.
- W2479430346 hasConcept C86803240 @default.
- W2479430346 hasConcept C98424977 @default.
- W2479430346 hasConceptScore W2479430346C104317684 @default.
- W2479430346 hasConceptScore W2479430346C119056186 @default.
- W2479430346 hasConceptScore W2479430346C121608353 @default.
- W2479430346 hasConceptScore W2479430346C1491633281 @default.
- W2479430346 hasConceptScore W2479430346C153911025 @default.
- W2479430346 hasConceptScore W2479430346C166703698 @default.
- W2479430346 hasConceptScore W2479430346C173396325 @default.
- W2479430346 hasConceptScore W2479430346C185592680 @default.
- W2479430346 hasConceptScore W2479430346C190283241 @default.
- W2479430346 hasConceptScore W2479430346C22615655 @default.
- W2479430346 hasConceptScore W2479430346C2777366897 @default.
- W2479430346 hasConceptScore W2479430346C2779723316 @default.
- W2479430346 hasConceptScore W2479430346C2780192828 @default.
- W2479430346 hasConceptScore W2479430346C2780783641 @default.
- W2479430346 hasConceptScore W2479430346C31573885 @default.
- W2479430346 hasConceptScore W2479430346C33195913 @default.
- W2479430346 hasConceptScore W2479430346C502942594 @default.
- W2479430346 hasConceptScore W2479430346C54009773 @default.
- W2479430346 hasConceptScore W2479430346C54355233 @default.
- W2479430346 hasConceptScore W2479430346C55493867 @default.
- W2479430346 hasConceptScore W2479430346C67705224 @default.
- W2479430346 hasConceptScore W2479430346C86803240 @default.
- W2479430346 hasConceptScore W2479430346C98424977 @default.
- W2479430346 hasLocation W24794303461 @default.
- W2479430346 hasOpenAccess W2479430346 @default.
- W2479430346 hasPrimaryLocation W24794303461 @default.
- W2479430346 hasRelatedWork W1510019806 @default.
- W2479430346 hasRelatedWork W1986771356 @default.
- W2479430346 hasRelatedWork W1987907695 @default.
- W2479430346 hasRelatedWork W2012163030 @default.
- W2479430346 hasRelatedWork W2025649858 @default.
- W2479430346 hasRelatedWork W2084891840 @default.
- W2479430346 hasRelatedWork W2101741389 @default.
- W2479430346 hasRelatedWork W2319177422 @default.
- W2479430346 hasRelatedWork W2320365283 @default.
- W2479430346 hasRelatedWork W2321781622 @default.
- W2479430346 hasRelatedWork W2352311081 @default.
- W2479430346 hasRelatedWork W2363563242 @default.
- W2479430346 hasRelatedWork W2366071737 @default.
- W2479430346 hasRelatedWork W2369013364 @default.
- W2479430346 hasRelatedWork W2407440884 @default.
- W2479430346 hasRelatedWork W2489923882 @default.
- W2479430346 hasRelatedWork W2548649213 @default.
- W2479430346 hasRelatedWork W2590908302 @default.
- W2479430346 hasRelatedWork W3029399906 @default.
- W2479430346 hasRelatedWork W6656056 @default.
- W2479430346 isParatext "false" @default.
- W2479430346 isRetracted "false" @default.
- W2479430346 magId "2479430346" @default.
- W2479430346 workType "article" @default.